ABCC4 and neoplasm: MRP4 could be a contributing factor in the accumulation of PGE2 in the tumor microenvironment preferentially in TNBC and basal subtype tumors compared to luminal breast tumors and should be considered as a potential molecular target in this subtype with overall poor outcomes.